发明名称 |
Combination Therapies For Hematologic Malignancies |
摘要 |
The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administration of a compound of formula A, wherein R is H, halo, or C1-C6 alkyl; R′ is C1-C6 alkyl; or a pharmaceutically acceptable salt thereof; and optionally a pharmaceutically acceptable excipient; and one or more additional therapeutic agents optionally selected from the group consisting of bendamustine, rituximab, and ofatumumab. |
申请公布号 |
SG10201601909T(A) |
申请公布日期 |
2016.04.28 |
申请号 |
SGT10201601909 |
申请日期 |
2012.03.09 |
申请人 |
GILEAD CALISTOGA LLC |
发明人 |
GALLATIN, MICHAEL;ULRICH, ROGER, G.;GIESE, NEILL, A.;LANNUTTI, BRIAN;YU, ALBERT;MILLER, LANGDON;JAHN, THOMAS, M. |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|